|
|
Managing Director - Menlo Park, California
|
 |
Marc Galletti is a founder and Managing Director of Longitude Capital. He focuses on investments in medical devices and specialty pharmaceuticals, including drug-device combinations.
From 2003 to 2006, Mr. Galletti was a Senior Vice President of Pequot Ventures where he worked in the life sciences practice. Prior to Pequot, Mr. Galletti worked at Amerindo Investment Advisors and Vector Fund Management where prior venture capital investments included Align Technology (NASDAQ: ALGN), CancerVax (acquired by Micromet), Eyetech Pharmaceuticals (NASDAQ: OSIP) and Theravance (NASDAQ: THRX). Mr. Galletti has also worked in the Global Healthcare Investment Banking Group at J.P. Morgan & Co. Mr. Galletti began his life sciences industry career 16 years ago at APM, a management consultancy dedicated to improving operations performance within large acute-care hospitals.
He currently serves on the Board of Velomedix and he has been a board member or board observer of Altiva Corporation, Aptus Endosystems, Broncus Technologies, Facet Solutions, MAP Pharmaceuticals (NASDAQ: MAPP), Sadra Medical, Sanarus Medical and Threshold Pharmaceuticals (NASDAQ: THLD). He also sits on the advisory boards for the Center of Biotechnology Management at the Kellogg School of Management and the Program for Biomedical Engineering at Brown University.
Mr. Galletti holds an M.B.A. from the Kellogg School of Management at Northwestern University and an A.B. from Princeton University.
|
|
|
|
